Skip to main content

Schakowsky and Blumenthal Lead Call for Trump Administration to Halt Program Expanding Surveillance of Americans' ED Visits, Raise Privacy Concerns About Use of AI to Analyze Patient Data

November 9, 2026

Full Text of Letter (PDF)

WASHINGTON – Today, U.S. Representative Jan Schakowsky (IL-09) and U.S. Senator Richard Blumenthal (D-CT) led a letter to U.S. Consumer Product Safety Commission (CPSC) Acting Chair Peter Feldman demanding answers about the Trump Administration’s proposed changes to a program used to inform product safety recalls that would expand surveillance of Americans’ emergency department records and risk patients’ privacy. In their letter to Feldman, Schakowsky, Blumenthal, U.S. Representative Kevin Mullin (CA-15), and U.S. Senator Adam Schiff (D-CA), raised concerns that the CPSC’s proposed changes to the National Electronic Injury Surveillance System (NEISS) unnecessarily expands the scope of the program’s surveillance efforts and exposes patient data to security risks due to the implementation of artificial intelligence (AI) in the program.

“The NEISS is an important tool that allows the CPSC to monitor product safety trends and issue product recalls or warnings to protect consumers. However, a review of the proposed NEISS-Remodel (NEISS-R) raises serious concerns about potential violations of agency process, changes to data collection that could impact agency rulemaking, and the use of AI,” the lawmakers wrote.

The lawmakers continued, “As you know, the NEISS allows hospitals across the country to voluntarily submit information on emergency department visits involving consumer products. With this information, the CPSC is able to produce estimates of product-related injuries, monitor safety trends, and determine if a product recall or warning is necessary. On July 22, 2026, the CPSC announced an update to the system that will dramatically increase the scope of its surveillance and the use of AI.

The lawmakers continued, “Based on the novel nature of AI and the plethora of concerns that have been raised by experts, including AI industry leaders, it is essential that the CPSC seek appropriate input from relevant stakeholders – as required by law – before exposing patient data to undue risk. Therefore, we continue to strongly urge the CPSC to hold off on further action until the proper procedures are followed.”

The lawmakers also raised concerns about the CPSC’s intention to expand data collection under the NEISS-R program, “Historically, hospitals have been instructed to exclude reports on emergency department visits outside of the CPSC’s jurisdiction.  Based on public reporting, the NEISS-R appears to be effectively eliminating that guidance and dramatically expanding data collection efforts to include more than 10,000 injury codes. This includes incidents with no relation to consumer products governed by the CPSC, including both suicide attempts and vaccines.”

The lawmakers continued, “Given President Donald Trump’s recent claims that widely used vaccines could be ‘quite lethal’, these actions raise concerns that yet another formerly nonpartisan arm of government has been conscripted into Health and Human Services Secretary Robert F. Kennedy’s relentless search for data to bolster his unsupported theories about the dangers of approved vaccines.”

The lawmakers called on CPSC to halt the implementation of NIESS-R in light of privacy concerns and a lack of transparency involving its implementation process “The use of AI has the potential to expose patient data to unnecessary security risks, including unintended data breaches and the improper use of individuals’ data to train current or future AI systems. Some of these concerns have already been echoed by former CPSC officials who explained the liability associated with collecting and storing massive amounts of data…Americans deserve the certainty that their personal health information is safe and that the CPSC is adequately managing the roll out of NEISS-R.”

###